| PRLR |
PRLR: Prolactin receptor precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
3.715 |
Evidence |
|
| ITGB4 |
IPI00027422 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
3.715 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
3.715 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
ALOX5 |
ALOX5, LOG5: Arachidonate 5-lipoxygenase |
3.715 |
Evidence |
|
| RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
ELA3B |
ELA3B: Elastase-3B precursor |
3.715 |
Evidence |
|
| CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.712 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
3.712 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.71 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
LIG1 |
LIG1: DNA ligase 1 |
3.71 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
MTIF2 |
MTIF2: Translation initiation factor IF-2, mitochondrial precursor |
3.71 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
3.707 |
Evidence |
|
| CR1L |
complement component (3b/4b) receptor 1-like |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.705 |
Evidence |
|
| KLK9 |
KLK9: Kallikrein-9 precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.705 |
Evidence |
|
| FGF21 |
FGF21, UNQ3115/PRO10196: Fibroblast growth factor 21 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
3.705 |
Evidence |
|
| RANBP3 |
RANBP3: Ran-binding protein 3 |
IPO11 |
IPO11, RANBP11: Importin-11 |
3.705 |
Evidence |
|
| MUC13 |
MUC13, DRCC1, UNQ6194/PRO20221, RECC: Mucin-13 precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.705 |
Evidence |
|
| CFC1 |
CFC1: Cryptic protein precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
3.705 |
Evidence |
|
| PRRG4 |
PRRG4, TMG4: Transmembrane gamma-carboxyglutamic acid protein 4 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
3.705 |
Evidence |
|
| CARD14 |
CARD14, CARMA2: Caspase recruitment domain-containing protein 14 |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
3.705 |
Evidence |
|
| MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
3.705 |
Evidence |
|
| MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
OSBPL6 |
OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 |
3.705 |
Evidence |
|
| DOK1 |
DOK1: Docking protein 1 |
MID2 |
IPI00514022 |
3.705 |
Evidence |
|
| ARHGEF1 |
ARHGEF1: Rho guanine nucleotide exchange factor 1 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
3.705 |
Evidence |
|
| ARHGEF1 |
ARHGEF1: Rho guanine nucleotide exchange factor 1 |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
3.705 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
DUX2 |
DUX2: Putative double homeobox protein 2 |
3.705 |
Evidence |
|